[Healthcare Target] ③ Successful Localization of Stem Cell Extraction Device “Smart Mcell 2”
Miracell Wins the Ministry of Food and Drug Safety Commissioner’s Award (Innovative Medical Sector)
Smart Mcell 2, World-Leading Cell Viability and Recovery Rates
Also Selected as a National Innovative Company
By Kim Young-hwan
[Edaily Reporter Kim Young-hwan] Stem cell specialist Miracell Co., Ltd. received the Minister of Food and Drug Safety Award (Innovative Medical Category) at the Edaily Global Healthcare Awards. This recognition recognizes the company’s technological achievements in researching and developing cell extraction systems to establish stem cell treatments in Korea.
Miracell successfully developed and domestically produced the “Smart M-Cell 2” stem cell extraction equipment and kit, which boast world-leading cell viability and recovery rates. Smart M-Cell 2 is a cutting-edge “bone marrow and blood stem cell manufacturing” system that extracts hematopoietic stem cells (CD34+) from blood and mesenchymal stem cells from bone marrow using biological drug manufacturing technology.
According to experimental results from Seoul National University Bundang Hospital, Smart M-Cell 2 demonstrated cell counts and viability rates comparable to or exceeding those of the world’s leading product, SmartPrep from the United States. Approximately 2.9 billion cells can be separated and extracted in one session, achieving a cell viability rate of 80-98%. Another notable feature is its closed system, which prevents air contact and prevents cell deformation. Smart Mcell 2 is currently used in major hospitals in Korea.
In May, Miracell was selected as a “National Representative Innovative Company” by the government. The National Representative Innovative Company program evaluates promising companies possessing patents and core technologies in various fields and selects companies that will lead innovation-driven growth industries.
In February, Miracell also received NET (No. 179) certification from the Ministry of Health and Welfare for its “Bone Marrow Blood Stem Cell Extraction Device Including a Centrifuge for Selective Separation.”